ATE309980T1 - Zubereitungen zur verwendung als therapeutische und nachweismittel - Google Patents

Zubereitungen zur verwendung als therapeutische und nachweismittel

Info

Publication number
ATE309980T1
ATE309980T1 AT97949046T AT97949046T ATE309980T1 AT E309980 T1 ATE309980 T1 AT E309980T1 AT 97949046 T AT97949046 T AT 97949046T AT 97949046 T AT97949046 T AT 97949046T AT E309980 T1 ATE309980 T1 AT E309980T1
Authority
AT
Austria
Prior art keywords
thrag
tyrx
therapeutic
preparations
drugs
Prior art date
Application number
AT97949046T
Other languages
English (en)
Inventor
Patrick Anthony Riley
Andrew Photiou
Tariq Hussain Khan
Helen Mary Isted Osborn
Original Assignee
Patrick Anthony Riley
Andrew Photiou
Tariq Hussain Khan
Helen Mary Isted Osborn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick Anthony Riley, Andrew Photiou, Tariq Hussain Khan, Helen Mary Isted Osborn filed Critical Patrick Anthony Riley
Application granted granted Critical
Publication of ATE309980T1 publication Critical patent/ATE309980T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/04Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97949046T 1996-12-13 1997-12-12 Zubereitungen zur verwendung als therapeutische und nachweismittel ATE309980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9625895.9A GB9625895D0 (en) 1996-12-13 1996-12-13 Novel compound useful as therapeutic agents and assay reagents
PCT/GB1997/003433 WO1998025886A1 (en) 1996-12-13 1997-12-12 Novel compounds useful as therapeutic agents and assay reagents

Publications (1)

Publication Number Publication Date
ATE309980T1 true ATE309980T1 (de) 2005-12-15

Family

ID=10804381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949046T ATE309980T1 (de) 1996-12-13 1997-12-12 Zubereitungen zur verwendung als therapeutische und nachweismittel

Country Status (7)

Country Link
US (1) US6573284B1 (de)
EP (1) EP0944583B1 (de)
AT (1) ATE309980T1 (de)
AU (1) AU748957B2 (de)
DE (1) DE69734670T2 (de)
GB (1) GB9625895D0 (de)
WO (1) WO1998025886A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014652A1 (en) * 2000-06-01 2004-01-22 Andre Trouet Tumor activated prodrug compounds and methods of making and using the same
AU7570201A (en) * 2000-07-26 2002-02-05 Riley Patrick Anthony Phenylethylamine derivatives and their use in the treatment of melanoma
WO2002024613A2 (en) * 2000-09-21 2002-03-28 Pfizer Products, Inc. Resorcinol derivatives
AU2004222439B2 (en) * 2003-03-20 2008-08-21 Nanocarrier Kabushiki Kaisha Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
DK1792927T3 (da) * 2004-09-22 2013-06-10 Nippon Kayaku Kk Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
CN101448875A (zh) * 2006-05-18 2009-06-03 日本化药株式会社 鬼臼毒素类的高分子量结合体
ES2584840T3 (es) * 2006-10-03 2016-09-29 Nippon Kayaku Kabushiki Kaisha Compuesto de un derivado de resorcinol con un polímero
MX363435B (es) 2007-03-22 2019-03-22 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
JP5349318B2 (ja) 2007-09-28 2013-11-20 日本化薬株式会社 ステロイド類の高分子結合体
JP5687899B2 (ja) * 2008-03-18 2015-03-25 日本化薬株式会社 生理活性物質の高分子結合体
AU2009233785B2 (en) 2008-04-11 2015-08-20 Berg Llc Methods and use of inducing apoptosis in cancer cells
US9149540B2 (en) * 2008-05-08 2015-10-06 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
BRPI1010576A2 (pt) 2009-05-11 2016-03-15 Berg Biosystems Llc métodos para tratamento de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais.
EP2431403B1 (de) 2009-05-15 2016-09-28 Nipponkayaku Kabushikikaisha Polymerkonjugat aus einer bioaktiven substanz mit einer hydroxidgruppe
PT2544663T (pt) * 2010-03-12 2018-04-05 Berg Llc Formulações intravenosas de coenzima q10 (coq10) e métodos de uso da mesma
TW201304805A (zh) 2010-11-17 2013-02-01 Nippon Kayaku Kk 新穎之胞核苷系代謝拮抗劑之高分子衍生物
EP2694463B8 (de) 2011-04-04 2019-10-09 Berg LLC Behandlung von tumoren im zentralnervensystem mit coenzym q10
AU2012271274B2 (en) 2011-06-17 2017-07-27 Berg Llc Inhalable pharmaceutical compositions
WO2013035641A1 (ja) 2011-09-11 2013-03-14 日本化薬株式会社 ブロック共重合体の製造方法
SG11201508272YA (en) 2013-04-08 2015-11-27 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムq10の連続注入によるがんの治療方法
WO2015157471A1 (en) 2014-04-08 2015-10-15 The Methodist Hospital Inos-inhibitory compositions and their use as breast cancer therapeutics
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
US12576166B2 (en) 2020-07-27 2026-03-17 Board Of Regents, The University Of Texas System Contrast agents for detection of enzyme activities based on melanin synthesis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543630A1 (de) * 1966-12-23 1969-07-31 Bayer Ag Verfahren zur Herstellung von tert. Butyloxycarbonylderivaten von Aminosaeuren
CH547799A (de) * 1970-10-30 1974-04-11 Hoffmann La Roche Verfahren zur herstellung von indolinderivaten.
US3801624A (en) * 1970-12-09 1974-04-02 Aldrich Chem Co Inc Di-substituted beta-phenethylcarbamic acid esters
IT1048122B (it) * 1973-05-23 1980-11-20 Simes Carbammati di ergoline
DE2448257A1 (de) * 1974-10-10 1976-04-22 Troponwerke Dinklage & Co Cumarinabkoemmlinge, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4115539A (en) * 1976-05-17 1978-09-19 Union Carbide Corporation Analytical or clinical derivatives, tagged derivatives and methods of analysis using such derivatives
US4812590A (en) * 1987-06-25 1989-03-14 Merck & Co., Inc. Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
FR2699532B1 (fr) * 1992-12-18 1995-02-24 Oreal Nouveaux composés indolines, compositions tinctoriales à base de ces composés et procédé de teinture des fibres kératiniques.
JPH0782280A (ja) * 1993-06-30 1995-03-28 Kanebo Ltd 新規なプロドラッグおよびその製造方法
CA2173150C (en) * 1993-10-01 2004-11-30 Kyoichi Sakakibara Novel peptide derivatives
GB9320660D0 (en) * 1993-10-07 1993-11-24 British Bio Technology Inhibition of cytokine production
CA2155448A1 (en) * 1994-08-11 1996-02-12 Katerina Leftheris Inhibitors of farnesyl protein transferase

Also Published As

Publication number Publication date
EP0944583A1 (de) 1999-09-29
AU7846998A (en) 1998-07-03
US6573284B1 (en) 2003-06-03
DE69734670T2 (de) 2006-06-29
AU748957B2 (en) 2002-06-13
WO1998025886A1 (en) 1998-06-18
GB9625895D0 (en) 1997-01-29
DE69734670D1 (de) 2005-12-22
EP0944583B1 (de) 2005-11-16

Similar Documents

Publication Publication Date Title
ATE309980T1 (de) Zubereitungen zur verwendung als therapeutische und nachweismittel
BG106771A (en) Heterocyclic substituted pyrazolones
BR1101081A (pt) Composto e composição farmacêutica
YU40701A (sh) Piperidini kao modulatori ccr5
DE69329240D1 (de) 17-ether und thioether von 4-aza-steroiden
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
PT966465E (pt) Inibidores do enzima imfdh
TR199901578T2 (xx) Klaritromisin form 0 kristali
CA2350073A1 (en) Ccr5 modulators
DE69329856D1 (de) Ester derivate von 4-aza-steroiden
DE69432035D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
DE68928667D1 (de) Peptide als arzneimittel
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
ATE255584T1 (de) Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
DE69842133D1 (de) Zusammensetzungen und Kits zur Erhöhung der Abgabe von therapeutischen Mitteln an Zellen
TR199800521T1 (xx) Se�imli beta3 adrenerjik agonistler.
ES2145021T3 (es) Derivados de 1-bifenil-piridona, su preparacion y su uso como antagonistas de la angiotensina ii.
ATE323495T1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
ATE451107T1 (de) 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
Dolence et al. Solid-phase synthesis of a radiolabeled, biotinylated, and farnesylated Ca1a2X peptide substrate for Ras-and a-mating factor converting enzyme
DE60022879D1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties